ETFs - Profile

VanEck Vectors Biotech ETF

GL > Health/Biotechnology >

Rank

Universe Rank
7 1

Summary

Philosophy Strategy Process Reaserch Risk Management

Price

  • Last Close
  • $207.54
    -11.07
  • 52 Week HL
  • $220.75 - $151.78
  • Net Assets
  • $590.12 M
  • Expense Ratio

Portfolio

  • Holdings
  • -
  • Turnover Ratio
  • -

Performance
19.2 % YTD

  • 3 Year
  • 82.57%
  • 5 Year
  • 77.82%
  • Best
  • 65.46%
    2013
  • Worst
  • -34.21%
    2002

Returns +
A

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
BBH 19%22%26%-11%17%-15%10%30%66%47%22%
S&P 500 21%16%29%-6%19%10%-1%11%0%13%0%

Returns +
Q

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
Q1 1.8% -8.2% 16.1% -3.4% 10.7% -18.3% 12.3% 2.7% 21.5% 22.2% -
Q2 11.5% 27.3% 0.1% 3.6% 5.5% -1.3% 4.1% 4.9% 5.8% 5.9% -
Q3 1.8% -1.5% -9.2% 13.1% 6.8% 12.6% -15.2% 11% 15.7% 11.9% -
Q4 - 5.7% 18.2% -17.6% -7.8% -6.4% 11.4% 9% 7% -1.6% -

Returns +
M

J F M A M J J A S O N D
2021 10.2% -4.4% -3.3% 9.4% -3.4% 8.3% 5% 4.3% -6.5% - - -
2020 -5% -0.3% -3.1% 15.9% 8.5% 1.3% 6.7% -7.7% - -4.1% 10% 0.1%

Annual Return

Index Comparison

Alpha

NAV